Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Lepem1flox/Cya
Common Name:
Lep-flox
Product ID:
S-CKO-03377
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Lep-flox
Strain ID
CKOCMP-16846-Lep-B6J-VA
Gene Name
Lep
Product ID
S-CKO-03377
Gene Alias
ob; obese
Background
C57BL/6JCya
NCBI ID
16846
Modification
Conditional knockout
Chromosome
6
Phenotype
MGI:104663
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Lepem1flox/Cya mice (Catalog S-CKO-03377) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000069789
NCBI RefSeq
NM_008493
Target Region
Exon 3
Size of Effective Region
~3.8 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Lep, which encodes leptin, is a crucial gene. Leptin is a hormone mainly produced by adipose tissue and is a key regulator of energy balance, acting on the hypothalamus to regulate appetite and metabolism. It is also involved in multiple biological processes such as inflammation, fibrosis, and cell growth [1,2,5].

Lep seems to have a dual-edged role in wound healing. It exerts pro-inflammatory and profibrotic effects, but can also regulate hair follicle growth, making it a potential target for promoting scarless wound healing [1].

In breast cancer, LEP is downregulated in cancer tissues compared to normal tissues, and low LEP expression is associated with a poorer prognosis, suggesting it could be a potential biomarker and therapeutic target [2].

Regarding non-Hodgkin lymphoma, the LEP G2528A polymorphism may increase the risk, while the A19G polymorphism may decrease the risk, especially for follicular lymphoma [3]. Some LEP gene variants like rs7799039 may be associated with energy intake [4].

In bovine intramuscular preadipocytes, LEP inhibits adipogenesis through the AMPK signaling pathway [5].

In preeclampsia, miR-519d can downregulate LEP expression to inhibit the development of the disease [6].

In myeloid neoplasms, hypermethylation of the LEP promoter is an early event and is associated with a worse prognosis [7].

In the Ukrainian population, the LEPR gene polymorphism (rs1137101) may be related to the metabolic syndrome, and the presence of its alleles affects the level of leptin and other hormones [8].

In Prader-Willi syndrome, there are alterations in serum leptin and LEP/LEPR promoter methylation [9].

In conclusion, Lep is essential in regulating energy balance, and its dysregulation is associated with various diseases including wound-related fibrotic disorders, breast cancer, non-Hodgkin lymphoma, preeclampsia, myeloid neoplasms, the metabolic syndrome, and Prader-Willi syndrome. Studies on Lep, especially through genetic models, help understand the biological processes and mechanisms underlying these diseases, potentially providing new strategies for diagnosis and treatment.

References:
1. Zhang, Kai-Wen, Jia, Yuan, Li, Yue-Yue, Yuan, Zheng-Dong, Yuan, Feng-Lai. 2022. LEP and LEPR are possibly a double-edged sword for wound healing. In Journal of cellular physiology, 238, 355-365. doi:10.1002/jcp.30936. https://pubmed.ncbi.nlm.nih.gov/36571294/
2. Jin, Tong Yi, Saindane, Madhuri, Park, Kyoung Sik, Yang, Jung-Hyun, Yun, IkJin. . LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA). In Medicine, 100, e26896. doi:10.1097/MD.0000000000026896. https://pubmed.ncbi.nlm.nih.gov/34414945/
3. Lin, Hai-Yan, Shi, Hui, Li, Chun-Yan, Liu, Peng-Cheng, Lou, Lie-ming. . LEP and LEPR polymorphisms in non-Hodgkin lymphoma risk: a systematic review and pooled analysis. In Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 20, 261-8. doi:. https://pubmed.ncbi.nlm.nih.gov/25778326/
4. Kroll, Caroline, Mastroeni, Silmara S B S, Veugelers, Paul J, Mastroeni, Marco F. 2019. Associations of ADIPOQ and LEP Gene Variants with Energy Intake: A Systematic Review. In Nutrients, 11, . doi:10.3390/nu11040750. https://pubmed.ncbi.nlm.nih.gov/30935050/
5. Yu, Shengchen, Yu, Hengwei, Wang, Jianfang, Mei, Chugang, Zan, Linsen. . LEP inhibits intramuscular adipogenesis through the AMPK signaling pathway in vitro. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 38, e23836. doi:10.1096/fj.202400590RR. https://pubmed.ncbi.nlm.nih.gov/39044640/
6. Cai, Hairui, Li, Dongmei, Wu, Jun, Shi, Chunbo. 2021. miR-519d downregulates LEP expression to inhibit preeclampsia development. In Open medicine (Warsaw, Poland), 16, 1215-1227. doi:10.1515/med-2021-0244. https://pubmed.ncbi.nlm.nih.gov/34514168/
7. Kaastrup, Katja, Gillberg, Linn, Mikkelsen, Stine U, Hansen, Jakob W, Grønbæk, Kirsten. 2023. LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome. In Clinical epigenetics, 15, 91. doi:10.1186/s13148-023-01505-w. https://pubmed.ncbi.nlm.nih.gov/37237325/
8. Prodan, Andrii, Dzubanovsky, Ihor, Kamyshnyi, Oleksandr, Pidruchna, Svitlana, Voloshyn, Stanislava. 2023. GHRL, LEP, LEPR genes polymorphism and their association with the metabolic syndrome in the Ukrainian population. In Endocrine regulations, 57, 269-278. doi:10.2478/enr-2023-0030. https://pubmed.ncbi.nlm.nih.gov/38127688/
9. Wieting, Jelte, Jahn, Kirsten, Buchholz, Vanessa, Deest, Maximilian, Frieling, Helge. 2022. Alteration of serum leptin and LEP/LEPR promoter methylation in Prader-Willi syndrome. In Psychoneuroendocrinology, 143, 105857. doi:10.1016/j.psyneuen.2022.105857. https://pubmed.ncbi.nlm.nih.gov/35803048/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest